Search


 
Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-8 of 8 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
First PublishedTitleAuthor(s)Type
1-Apr-2010Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab (vol 9, pg E36, 2009)Wierda, W; Kipps, T; Mayer, J; Stilgenbauer, S; Williams, CD; Hellmann, A; Robak, T; Furman, RR; Hillmen, P; Trneny, M; Dyer, MJS; Padmanabhan, S; Piotrowska, M; Kozak, T; Chan, G; Davis, R; Losic, N; Wilms, J; Russell, C; Osterborg, AJournal Article
1-Apr-2011Late Onset Bowel Dysfunction Post-pelvic Radiotherapy: a National Survey of Current Practice and Opinions of Clinical OncologistsHenson, C; Andreyev, HJ; Symonds, RP; Peel, D; Swindell, R; Davidson, SEJournal Article
1-Apr-2011Late Onset Bowel Dysfunction Post-pelvic Radiotherapy: a National Survey of Current Practice of GastroenterologistsHenson, C; Davidson, SE; Symonds, RP; Swindell, R; Andreyev, HJJournal Article
25-Aug-2015Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemiaSalaverria, I.; Martin-Garcia, D.; Lopez, C.; Clot, G.; Garcia-Aragones, M.; Navarro, A.; Delgado, J.; Baumann, T.; Pinyol, M.; Martin-Guerrero, I.; Carrio, A.; Costa, D.; Queiros, A. C.; Jayne, Sandrine; Aymerich, M.; Villamor, N.; Colomer, D.; Gonzalez, M.; Lopez-Guillermo, A.; Campo, E.; Dyer, Martin J. S.; Siebert, R.; Armengol, L.; Bea, S. L.Journal Article
5-Dec-2014Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia riskSava, G. P.; Speedy, H. E.; Di Bernardo, M. C.; Dyer, Martin J. S.; Holroyd, A.; Sunter, N. J.; Marr, H.; Mansouri, L.; Deaglios, S.; Karabon, L.; Frydecka, I.; Jamroziak, K.; Woszczyk, D.; Juliusson, G.; Smedby, K. E.; Jayne, S.; Majid, A.; Wang, Y.; Dearden, C.; Hall, A. G.; Mainou-Fowler, T; Jackson, G. H.; Summerfield, G.; Harris, R. J.; Pettitt, A. R.; Allsup, D. J.; Bailey, J. R.; Pratt, G.; Pepper, C.; Fegan, C.; Rosenquist, R.; Catovsky, D.; Allan, J. M.; Houlston, R. S.Journal Article
18-May-2010A TRAIL-R1-specific ligand in combination with doxorubicin selectively targets primary breast tumour cells for apoptosisTwiddy, D.; Naik, S.; Mistry, R.; Edwards, J.; Walker, Rosemary Ann; Cohen, G. M.; MacFarlane, M.Conference Paper
17-May-2019The essential role of prevention in reducing the cancer burden in Europe: a commentary from Cancer Prevention Europe.Espina, C; Bauld, L; Bonanni, B; Brenner, H; Brown, K; Dillner, J; Kampman, E; Nilbert, M; Vineis, P; Weijenberg, MP; Cox, A; de Kok, TM; Fecht, D; Mitrou, G; Muller, DC; Serrano, D; Steindorf, K; Storm, H; Thorat, MA; van Duijnhoven, F; Weiderpass, E; Schüz, JJournal Article
25-Jul-2018Factors that influence quality and yield of circulating-free DNA: A systematic review of the methodology literatureTrigg, R. M.; Martinson, L. J.; Parpart-Li, S.; Shaw, J. A.Journal Article